Publications by authors named "Will Fazzone"

Claim this Profile
T
The dual EGFR/HER2 inhibitor lapatinib synergistically enhances the antitumor activity of the histone deacetylase inhibitor panobinostat in colorectal cancer models.
Melissa J LaBonte, Peter M Wilson, Will Fazzone, Jared Russell, Stan G Louie

Cancer Res· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38.
Melissa J LaBonte, Philipp C Manegold, Peter M Wilson, Will Fazzone, Stan G Louie

Int J Cancer· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis